YEF-20966-64629
2 vaccinations
2 coded responses
23 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 279 / NC
- Registered
- 2021-08-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-20
Registered in v-safe
-
2021-08-20
Dose 1 — Moderna
- 2021-08-20
- 2021-08-21
- 2021-08-22
- 2021-08-23
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-08-27
- 2021-09-03
- 2021-09-10
-
2021-09-15
Dose 2 — Moderna
-
2021-09-15
Survey response — day 0, dose 2MedDRA: Nasal congestion — Feeling: Fair · Site: Pain, Swelling · HeadacheFree text: Nasal congestionMedDRA releases: 2024-11 · check-in free text available
-
2021-09-16
Survey response — days 1–6 daily, dose 2MedDRA: Paranasal sinus hypersecretion — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tirednessFree text: Sinus drainageMedDRA releases: 2024-11 · check-in free text available
- 2021-09-18
- 2021-09-19
- 2021-09-20
- 2021-09-21
- 2021-09-22
- 2021-09-29
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-12-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-20 | Moderna | No |
| 2 | 2021-09-15 | Moderna | No |
Free text
Release 9 — day 0, dose 2
Systemic reaction (other): Nasal congestion
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Sinus drainage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Paranasal sinus hypersecretion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release